People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Manufacturing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elevance Renewable Sciences, Inc. | — | Manufacturing | Series D+ | $319.9M | $208.4M | 2010 |
| Zymeworks Inc. | — | Biotechnology | Series C | $143.3M | $2.5B | 2009 |
Patrick McCroskey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick McCroskey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Shapiro | 1 | 13 |
| Kenneth Galbraith | 1 | 6 |
| Geoff Duyk | 1 | 5 |
| Patrick Kelly | 1 | 4 |
| David Tucker | 1 | 3 |
| Shermaine Tilley | 1 | 3 |
| STEVEN MILLS | 1 | 3 |
| Ian Ihnatowycz | 1 | 3 |
| WILLIAM MCGLASHAN | 1 | 3 |
| Noel Hall | 1 | 3 |
| DION MADSEN | 1 | 2 |
| Amos Michelson | 1 | 2 |
| Veronique Hervouet | 1 | 2 |
| Karl A. Schoene | 1 | 2 |
| K'LYNNE JOHNSON | 1 | 2 |
| Carole Piwnica | 1 | 2 |
| Nick Bedford | 1 | 2 |
| LIM KOK THAY | 1 | 2 |
| Donald Drakeman | 1 | 1 |
| Ali Tehrani | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.